Page last updated: 2024-09-03

mk 0663 and Periodontitis

mk 0663 has been researched along with Periodontitis in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (75.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Assreuy, J; Fernandes, D; Machado, WM; Mendes, RT; Olchanheski, LR; Santos, FA; Sordi, R; Stanczyk, CP	1
Azoubel, E; Azoubel, MC; Bittencourt, S; Brito, GA; Cangussú, V; Cunha, FQ; Ribeiro, RA; Sarmento, VA	1
Hebling, J; Holzhausen, M; Muscará, MN; Spolidorio, DM; Spolidorio, LC	1
Azoubel, MC; Bezerra, D; Brito, GA; Menezes, AM; Oriá, RB; Ribeiro, RA	1

Trials

1 trial(s) available for mk 0663 and Periodontitis

Article	Year
Adjunctive benefits of systemic etoricoxib in non-surgical treatment of aggressive periodontitis: short-term evaluation. Journal of periodontology, 2008, Volume: 79, Issue:9 Topics: Adolescent; Adult; Alveolar Bone Loss; Combined Modality Therapy; Cyclooxygenase Inhibitors; Dental Scaling; Dinoprostone; Double-Blind Method; Etoricoxib; Female; Follow-Up Studies; Gingival Crevicular Fluid; Gingival Hemorrhage; Humans; Male; Periodontal Attachment Loss; Periodontal Pocket; Periodontitis; Pilot Projects; Placebos; Pyridines; Root Planing; Sulfones; Tooth Cervix	2008

Article

Year

Adjunctive benefits of systemic etoricoxib in non-surgical treatment of aggressive periodontitis: short-term evaluation.

Journal of periodontology, 2008, Volume: 79, Issue:9

Topics: Adolescent; Adult; Alveolar Bone Loss; Combined Modality Therapy; Cyclooxygenase Inhibitors; Dental Scaling; Dinoprostone; Double-Blind Method; Etoricoxib; Female; Follow-Up Studies; Gingival Crevicular Fluid; Gingival Hemorrhage; Humans; Male; Periodontal Attachment Loss; Periodontal Pocket; Periodontitis; Pilot Projects; Placebos; Pyridines; Root Planing; Sulfones; Tooth Cervix

2008

Other Studies

3 other study(ies) available for mk 0663 and Periodontitis

Article	Year
Periodontitis increases vascular cyclooxygenase-2: potential effect on vascular tone. Journal of periodontal research, 2014, Volume: 49, Issue:1 Topics: Alveolar Bone Loss; Animals; Anti-Inflammatory Agents; Arterial Pressure; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Endothelium, Vascular; Etoricoxib; Heart Rate; Male; Mesenteric Arteries; Nitric Oxide; Periodontitis; Pyridines; Random Allocation; Rats, Wistar; Sulfones; Vasoconstrictor Agents; Vasodilator Agents	2014
Protective effects of etoricoxib, a selective inhibitor of cyclooxygenase-2, in experimental periodontitis in rats. Journal of periodontal research, 2005, Volume: 40, Issue:3 Topics: Alveolar Bone Loss; Animals; Cyclooxygenase Inhibitors; Drug Evaluation, Preclinical; Etoricoxib; Leukocytosis; Lymphocytes; Male; Mandibular Diseases; Periodontitis; Pyridines; Random Allocation; Rats; Rats, Wistar; Sulfones	2005
Comparison of etoricoxib and indomethacin for the treatment of experimental periodontitis in rats. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2007, Volume: 40, Issue:1 Topics: Alveolar Bone Loss; Animals; Cyclooxygenase Inhibitors; Etoricoxib; Female; Gastric Mucosa; Indomethacin; Intestinal Mucosa; Periodontitis; Pyridines; Rats; Rats, Wistar; Sulfones	2007